N-1 perfusion platform technology development, implementation, and business case analysis in commercial manufacturing

Authors

• Jianlin Xu, Sanofi, USAFollow
• Jonathan Forstrom, MSAT Recombinant Mammalian DS Platform, Sanofi
• Elien Van Sinay, MSAT Recombinant Mammalian DS Platform, Sanofi
• Yang Wu, Cell Culture Development, Mammalian Platform, Sanofi
• Henry Lin, Cell Culture Development, Mammalian Platform, Sanofi
• Charles Budde, Cell Culture Development, Mammalian Platform, Sanofi
• Agathe Drape, Cell Culture Development, Mammalian Platform, Sanofi

Conference Dates

April 27 - May 2, 2025

Abstract

Please click Additional Files below to see the full abstract

Recommended Citation

Jianlin Xu, Jonathan Forstrom, Elien Van Sinay, Yang Wu, Henry Lin, Charles Budde, and Agathe Drape, "N-1 perfusion platform technology development, implementation, and business case analysis in commercial manufacturing" in "Cell Culture Engineering XIX", A Khetan, BMS; Marcella Yu, Gilead; Mike Betenbaugh, Johns Hopkins University Eds, ECI Symposium Series, (2025). https://dc.engconfintl.org/cell_culture_engineering_xix/190